PDL BIOPHARMA INC's ticker is and the CUSIP is 69329Y10. A total of 4 filers reported holding PDL BIOPHARMA INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $1,223,000 | -6.4% | 365,050 | -12.2% | 0.00% | 0.0% |
Q2 2016 | $1,306,000 | -32.5% | 415,858 | -28.4% | 0.00% | -50.0% |
Q1 2016 | $1,935,000 | +5.5% | 580,969 | +12.2% | 0.01% | 0.0% |
Q4 2015 | $1,834,000 | +422.5% | 518,000 | +642.1% | 0.01% | +700.0% |
Q3 2015 | $351,000 | -95.5% | 69,800 | -92.6% | 0.00% | -97.9% |
Q1 2014 | $7,839,000 | -49.4% | 943,334 | -48.6% | 0.05% | -44.0% |
Q4 2013 | $15,491,000 | +48.4% | 1,835,437 | +40.2% | 0.08% | +27.3% |
Q3 2013 | $10,436,000 | -5.3% | 1,309,377 | -8.3% | 0.07% | -19.5% |
Q2 2013 | $11,019,000 | – | 1,427,324 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1,309,377 | $10,436,000 | 0.07% |
NJ State Employees Deferred Compensation Plan | 8,000 | $64,000 | 0.01% |
INGALLS & SNYDER LLC | 25,600 | $204,000 | 0.01% |
State of New Jersey Common Pension Fund A | 245,000 | $1,953,000 | 0.01% |